| Peer-Reviewed

Effectiveness of Intrauterine Insemination in Unexplained Infertility and Male Subfertility with Mild Form of Oligo Asthenoteratozoospermia

Received: 1 September 2022    Accepted: 30 September 2022    Published: 30 November 2022
Views:       Downloads:
Abstract

Introduction: Male infertility is typically determined through routine sperm analysis, but recent publications have called into question its diagnostic and prognostic accuracy, as well as the effectiveness of IUI itself. The aim of the study was to evaluate the pregnancy rate following IUI in unexplained infertility and male infertility (a mild form of oligo astheno teratozoospermia). Methods: This interventional study was carried out in the outpatient department (OPD) of the infertility Unit of Gynaecology and Obstetrics Department of Bangabandhu Sheikh Mujib Medical University, Dhaka, from July 2014 to June 2015. A total of 148 couples were enrolled, out of which 74 couples where only a male partner had oligospermia or asthenozoospermia or teratozoospermia were considered group I (case) and 74 couples had unexplained infertility was considered group II (control). All-female patients took Tab clomiphene citrate 100mg from D2-D5 and inj Menogon (75IU) I/M was received on D3 and D8. TVS for folliculometry was done from D9 onwards every alternate day. Statistical analysis of the results was obtained by using windows computer software with Statistical Packages for Social Sciences (SPSS-version 22). Result: Follicle was developed (≥17 mm) in 71 (96.0%) in group I and 68 (91.9%) in group II up to D13. Pre-wash motility <50 percent was found in all cases in group II and group II respectively. Post motility ≥50 percent was found in 10 (15.6%) in group I. The difference was statistically significant (p<0.05) between the two groups. Biochemical pregnancy occurs 3 (4.7%) in group I and 5 (8.5%) in group II. Clinical pregnancy 2 (3.1%) and 3 (5.1%) in group I and group II respectively. Biochemical and Clinical pregnancy differences were not statistically significant (p>0.05) between the two groups. Conclusion: Stimulated IUI should be the first choice treatment for mild male factor infertility, and unexplained infertility, which is a less costly and easy procedure. it can be done before going through more invasive and costly treatments like IVF or ICSI.

Published in American Journal of Applied Scientific Research (Volume 8, Issue 4)
DOI 10.11648/j.ajasr.20220804.15
Page(s) 99-106
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2024. Published by Science Publishing Group

Keywords

Intrauterine Insemination, Infertility, Subfertility, Oligo Asthenoteratozoospermia

References
[1] Zegers-Hochschild, F., Adamson, G. D., de Mouzon, J., Ishihara, O., Mansour, R., Nygren, K., Sullivan, E. and Van der Poel, S., 2009. The international committee for monitoring assisted reproductive technology (ICMART) and the world health organization (WHO) revised glossary on ART terminology, 2009. Human reproduction, 24 (11), pp. 2683-2687.
[2] Nallella, K. P., Sharma, R. K., Aziz, N. and Agarwal, A., 2006. Significance of sperm characteristics in the evaluation of male infertility. Fertility and sterility, 85 (3), pp. 629-634.
[3] Wadhwa, L., Fauzdar, A. and Wadhwa, S. N., 2018. An intrauterine insemination audit at tertiary care hospital: A 4½ years' retrospective analysis of 800 intrauterine insemination cycles. Journal of human reproductive sciences, 11 (3), pp. 279-285.
[4] Cooper, T. G., Noonan, E., Von Eckardstein, S., Auger, J., Baker, H. W., Behre, H. M., Haugen, T. B., Kruger, T., Wang, C., Mbizvo, M. T. and Vogelsong, K. M., 2010. World Health Organization reference values for human semen characteristics. Human reproduction update, 16 (3), pp. 231-245.
[5] Hirsh, A., 2003. Male subfertility. Bmj, 327 (7416), pp. 669-672.
[6] Scholten, I., van Zijl, M., Custers, I. M., Brandes, M., Gianotten, J., van der Linden, P. J., Hompes, P. G., van der Veen, F. and Mol, B. W., 2017. The effectiveness of intrauterine insemination: A matched cohort study. European Journal of Obstetrics & Gynecology and Reproductive Biology, 212, pp. 91-95.
[7] Goswami, G., Sharma, M., Jugga, D. and Gouri, D. M., 2018. Can intracytoplasmic morphologically selected spermatozoa injection be used as first choice of treatment for severe male factor infertility patients?. Journal of human reproductive sciences, 11 (1), pp. 40-44.
[8] Jo, J. and Kang, M. J., 2016. Successful treatment of oligoasthenozoospermia using traditional Korean medicine resulting in spontaneous pregnancy: two case reports. Explore, 12 (2), pp. 136-138.
[9] Rahman, F., Kutubi, A., Jabeen, S., Akter, Y. and Sultana, N., 2016. Study of Intrauterine Insemination (IUI) among 52 Cases in a Newly Established Infertility Care Centre of Dhaka Medical College Hospital. Journal of Shaheed Suhrawardy Medical College, 8 (2), pp. 49-53.
[10] Tang, Y., He, Q. D., Zhang, T. T., Wang, J. J., Huang, S. C. and Ye, Y., 2021. Controlled ovarian stimulation should not be preferred for male infertility treated with intrauterine insemination: a retrospective study. Reproductive Biology and Endocrinology, 19 (1), pp. 1-7.
[11] Soria, M., Pradillo, G., García, J., Ramón, P., Castillo, A., Jordana, C. and Paricio, P., 2012. Pregnancy predictors after intrauterine insemination: analysis of 3012 cycles in 1201 couples. Journal of reproduction & infertility, 13 (3), pp. 158-166.
[12] Peeraer, K., Debrock, S., De Loecker, P., Tomassetti, C., Laenen, A., Welkenhuysen, M., Meeuwis, L., Pelckmans, S., Mol, B. W., Spiessens, C. and De Neubourg, D., 2015. Low-dose human menopausal gonadotrophin versus clomiphene citrate in subfertile couples treated with intrauterine insemination: a randomized controlled trial. Human Reproduction, 30 (5), pp. 1079-1088.
[13] Benbella, A., Aboulmakarim, S., Hardizi, H., Zaidouni, A. and Bezad, R., 2018. Infertility in the Moroccan population: an etiological study in the reproductive health centre in Rabat. The Pan African Medical Journal, 30. p. 204.
[14] Parsanezhad, M. E., Jahromi, B. N., Zare, N., Keramati, P., Khalili, A. and Parsa-Nezhad, M., 2013. Epidemiology and etiology of infertility in Iran, systematic review and meta-analysis. J Womens Health, Issues Care, 2 (6), p. 2.
[15] Povey, A. C. and Stocks, S. J., 2010. Epidemiology and trends in male subfertility. Human fertility, 13 (4), pp. 182-188.
[16] Agarwal, A., Mulgund, A., Hamada, A. and Chyatte, M. R., 2015. A unique view on male infertility around the globe. Reproductive biology and endocrinology, 13 (1), pp. 1-9.
[17] Dorjpurev, U., Kuwahara, A., Yano, Y., Taniguchi, T., Yamamoto, Y., Suto, A., Tanaka, Y., Matsuzaki, T., Yasui, T. and Irahara, M., 2011. Effect of semen characteristics on pregnancy rate following intrauterine insemination. The Journal of Medical Investigation, 58 (1, 2), pp. 127-133.
[18] van Weert, J. M., Repping, S., Van Voorhis, B. J., Van Der Veen, F., Bossuyt, P. M. and Mol, B. W., 2004. Performance of the postwash total motile sperm count as a predictor of pregnancy at the time of intrauterine insemination: a meta-analysis. Fertility and sterility, 82 (3), pp. 612-620.
[19] Gubert, P. G., Pudwell, J., Van Vugt, D., Reid, R. L. and Velez, M. P., 2019. Number of motile spermatozoa inseminated and pregnancy outcomes in intrauterine insemination. Fertility research and practice, 5 (1), pp. 1-9.
[20] Cao, S., Zhao, C., Zhang, J., Wu, X., Zhou, L., Guo, X., Shen, R. and Ling, X., 2014. A minimum number of motile spermatozoa are required for successful fertilisation through artificial intrauterine insemination with husband's spermatozoa. Andrologia, 46 (5), pp. 529-534.
[21] Ombelet, W., Dhont, N., Thijssen, A., Bosmans, E. and Kruger, T., 2014. Semen quality and prediction of IUI success in male subfertility: a systematic review. Reproductive biomedicine online, 28 (3), pp. 300-309.
[22] Goldman, R. H., Batsis, M., Hacker, M. R., Souter, I. and Petrozza, J. C., 2014. Outcomes after intrauterine insemination are independent of provider type. American journal of obstetrics and gynecology, 211 (5), pp. 492-e1.
[23] Miller, D. C., Hollenbeck, B. K., Smith, G. D., Randolph, J. F., Christman, G. M., Smith, Y. R., Lebovic, D. I. and Ohl, D. A., 2002. Processed total motile sperm count correlates with pregnancy outcome after intrauterine insemination. Urology, 60 (3), pp. 497-501.
[24] Shulman, A., Hauser, R., Lipitz, S., Frenkel, Y., Dor, J., Bider, D., Mashiach, S., Yogev, L. and Yavetz, H., 1998. Sperm motility is a major determinant of pregnancy outcome following intrauterine insemination. Journal of assisted reproduction and genetics, 15 (6), pp. 381-385.
[25] Orvieto, R., Mohr-Sasson, A., Blumenfeld, S., Nahum, R., Aizer, A. and Haas, J., 2020. Does large (> 24mm) follicle yield a competent oocyte/embryo?.
[26] Abbara, A., Vuong, L. N., Ho, V. N., Clarke, S. A., Jeffers, L., Comninos, A. N., Salim, R., Ho, T. M., Kelsey, T. W., Trew, G. H. and Humaidan, P., 2018. Follicle size on day of trigger most likely to yield a mature oocyte. Frontiers in endocrinology, 9, p. 193.
[27] Revelli, A., Martiny, G., Delle Piane, L., Benedetto, C., Rinaudo, P. and Tur-Kaspa, I., 2014. A critical review of bi-dimensional and three-dimensional ultrasound techniques to monitor follicle growth: do they help improving IVF outcome?. Reproductive Biology and Endocrinology, 12 (1), pp. 1-9.
[28] Baerwald, A. R., Walker, R. A. and Pierson, R. A., 2009. Growth rates of ovarian follicles during natural menstrual cycles, oral contraception cycles, and ovarian stimulation cycles. Fertility and sterility, 91 (2), pp. 440-449.
[29] Panda, B., Mohapatra, L., Sahu, M. C. and Padhy, R. N., 2014. Success in pregnancy through intrauterine insemination at first cycle in 300 infertile couples: an analysis. The Journal of Obstetrics and Gynecology of India, 64 (2), pp. 134-142.
[30] Kamath, M. S., Bhave, P., Aleyamma, T. K., Nair, R., Chandy, A., Mangalaraj, A. M., Muthukumar, K. and George, K., 2010. Predictive factors for pregnancy after intrauterine insemination: A prospective study of factors affecting outcome. Journal of human reproductive sciences, 3 (3), pp. 129-134.
[31] Dankert, T., Kremer, J. A. M., Cohlen, B. J., Hamilton, C. J. C. M., Pasker-de Jong, P. C. M., Straatman, H. M. P. M. and Van Dop, P. A., 2007. A randomized clinical trial of clomiphene citrate versus low dose recombinant FSH for ovarian hyperstimulation in intrauterine insemination cycles for unexplained and male subfertility. Human Reproduction, 22 (3), pp. 792-797.
[32] Lotti, F. and Maggi, M., 2015. Ultrasound of the male genital tract in relation to male reproductive health. Human reproduction update, 21 (1), pp. 56-83.
[33] Björndahl, L., 2010. The usefulness and significance of assessing rapidly progressive spermatozoa. Asian Journal of Andrology, 12 (1), p. 33.
[34] Kumar, N. and Singh, A. K., 2015. Trends of male factor infertility, an important cause of infertility: A review of literature. Journal of human reproductive sciences, 8 (4), p. 191.
[35] Cocuzza, M. and Agarwal, A., 2007. Nonsurgical treatment of male infertility: specific and empiric therapy. Biologics: targets & therapy, 1 (3), pp. 259-269.
[36] Morshedi, M., Duran, H. E., Taylor, S. and Oehninger, S., 2003. Efficacy and pregnancy outcome of two methods of semen preparation for intrauterine insemination: a prospective randomized study. Fertility and sterility, 79, pp. 1625-1632.
[37] Elnashar, A. M., 2004. OPINION-Intrauterine insemination. Middle East Fertility Society Journal, 9 (2), pp. 101-106.
[38] Zadehmodarres, S., Oladi, B., Saeedi, S., Jahed, F. and Ashraf, H., 2009. Intrauterine insemination with husband semen: an evaluation of pregnancy rate and factors affecting outcome. Journal of assisted reproduction and genetics, 26 (1), pp. 7-11.
[39] Andersen, A. N., Gianaroli, L., Felberbaum, R., De Mouzon, J. and Nygren, K. G., 2006. Assisted reproductive technology in Europe, 2002. Results generated from European registers by ESHRE. Human Reproduction (Oxford, England), 21 (7), pp. 1680-1697.
[40] Haidl, G., 2002. Management strategies for male factor infertility. Drugs, 62 (12), pp. 1741-1753.
[41] March, M. R. and Isidori, A., 2002. New frontiers in the treatment of male sterility. Contraception, 65 (4), pp. 279-281.
[42] Siddiq, F. M. and Sigman, M., 2002. A new look at the medical management of infertility. Urologic Clinics, 29 (4), pp. 949-963.
[43] Evans, M. B., Stentz, N. C., Richter, K. S., Schexnayder, B., Connell, M., Healy, M. W., Devine, K., Widra, E., Stillman, R., DeCherney, A. H. and Hill, M. J., 2020. Mature follicle count and multiple gestation risk based on patient age in intrauterine insemination cycles with ovarian stimulation. Obstetrics & Gynecology, 135 (5), pp. 1005-1014.
[44] World Health Organisation, 1999. WHO laboratory manual for the examination of human semen and sperm-cervical mucus interaction. Cambridge university press.
[45] World Health Organisation, 1992. WHO laboratory manual for the examination of human semen and sperm-cervical mucus interaction. Cambridge university press.
Cite This Article
  • APA Style

    Masuma Amanullah, Mohammad Akram Ahsan, Mohammad Saiful Akram, Mohammad Samsul Arefin, Farhana Hasan, et al. (2022). Effectiveness of Intrauterine Insemination in Unexplained Infertility and Male Subfertility with Mild Form of Oligo Asthenoteratozoospermia. American Journal of Applied Scientific Research, 8(4), 99-106. https://doi.org/10.11648/j.ajasr.20220804.15

    Copy | Download

    ACS Style

    Masuma Amanullah; Mohammad Akram Ahsan; Mohammad Saiful Akram; Mohammad Samsul Arefin; Farhana Hasan, et al. Effectiveness of Intrauterine Insemination in Unexplained Infertility and Male Subfertility with Mild Form of Oligo Asthenoteratozoospermia. Am. J. Appl. Sci. Res. 2022, 8(4), 99-106. doi: 10.11648/j.ajasr.20220804.15

    Copy | Download

    AMA Style

    Masuma Amanullah, Mohammad Akram Ahsan, Mohammad Saiful Akram, Mohammad Samsul Arefin, Farhana Hasan, et al. Effectiveness of Intrauterine Insemination in Unexplained Infertility and Male Subfertility with Mild Form of Oligo Asthenoteratozoospermia. Am J Appl Sci Res. 2022;8(4):99-106. doi: 10.11648/j.ajasr.20220804.15

    Copy | Download

  • @article{10.11648/j.ajasr.20220804.15,
      author = {Masuma Amanullah and Mohammad Akram Ahsan and Mohammad Saiful Akram and Mohammad Samsul Arefin and Farhana Hasan and Sadia Tabassum},
      title = {Effectiveness of Intrauterine Insemination in Unexplained Infertility and Male Subfertility with Mild Form of Oligo Asthenoteratozoospermia},
      journal = {American Journal of Applied Scientific Research},
      volume = {8},
      number = {4},
      pages = {99-106},
      doi = {10.11648/j.ajasr.20220804.15},
      url = {https://doi.org/10.11648/j.ajasr.20220804.15},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajasr.20220804.15},
      abstract = {Introduction: Male infertility is typically determined through routine sperm analysis, but recent publications have called into question its diagnostic and prognostic accuracy, as well as the effectiveness of IUI itself. The aim of the study was to evaluate the pregnancy rate following IUI in unexplained infertility and male infertility (a mild form of oligo astheno teratozoospermia). Methods: This interventional study was carried out in the outpatient department (OPD) of the infertility Unit of Gynaecology and Obstetrics Department of Bangabandhu Sheikh Mujib Medical University, Dhaka, from July 2014 to June 2015. A total of 148 couples were enrolled, out of which 74 couples where only a male partner had oligospermia or asthenozoospermia or teratozoospermia were considered group I (case) and 74 couples had unexplained infertility was considered group II (control). All-female patients took Tab clomiphene citrate 100mg from D2-D5 and inj Menogon (75IU) I/M was received on D3 and D8. TVS for folliculometry was done from D9 onwards every alternate day. Statistical analysis of the results was obtained by using windows computer software with Statistical Packages for Social Sciences (SPSS-version 22). Result: Follicle was developed (≥17 mm) in 71 (96.0%) in group I and 68 (91.9%) in group II up to D13. Pre-wash motility 0.05) between the two groups. Conclusion: Stimulated IUI should be the first choice treatment for mild male factor infertility, and unexplained infertility, which is a less costly and easy procedure. it can be done before going through more invasive and costly treatments like IVF or ICSI.},
     year = {2022}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Effectiveness of Intrauterine Insemination in Unexplained Infertility and Male Subfertility with Mild Form of Oligo Asthenoteratozoospermia
    AU  - Masuma Amanullah
    AU  - Mohammad Akram Ahsan
    AU  - Mohammad Saiful Akram
    AU  - Mohammad Samsul Arefin
    AU  - Farhana Hasan
    AU  - Sadia Tabassum
    Y1  - 2022/11/30
    PY  - 2022
    N1  - https://doi.org/10.11648/j.ajasr.20220804.15
    DO  - 10.11648/j.ajasr.20220804.15
    T2  - American Journal of Applied Scientific Research
    JF  - American Journal of Applied Scientific Research
    JO  - American Journal of Applied Scientific Research
    SP  - 99
    EP  - 106
    PB  - Science Publishing Group
    SN  - 2471-9730
    UR  - https://doi.org/10.11648/j.ajasr.20220804.15
    AB  - Introduction: Male infertility is typically determined through routine sperm analysis, but recent publications have called into question its diagnostic and prognostic accuracy, as well as the effectiveness of IUI itself. The aim of the study was to evaluate the pregnancy rate following IUI in unexplained infertility and male infertility (a mild form of oligo astheno teratozoospermia). Methods: This interventional study was carried out in the outpatient department (OPD) of the infertility Unit of Gynaecology and Obstetrics Department of Bangabandhu Sheikh Mujib Medical University, Dhaka, from July 2014 to June 2015. A total of 148 couples were enrolled, out of which 74 couples where only a male partner had oligospermia or asthenozoospermia or teratozoospermia were considered group I (case) and 74 couples had unexplained infertility was considered group II (control). All-female patients took Tab clomiphene citrate 100mg from D2-D5 and inj Menogon (75IU) I/M was received on D3 and D8. TVS for folliculometry was done from D9 onwards every alternate day. Statistical analysis of the results was obtained by using windows computer software with Statistical Packages for Social Sciences (SPSS-version 22). Result: Follicle was developed (≥17 mm) in 71 (96.0%) in group I and 68 (91.9%) in group II up to D13. Pre-wash motility 0.05) between the two groups. Conclusion: Stimulated IUI should be the first choice treatment for mild male factor infertility, and unexplained infertility, which is a less costly and easy procedure. it can be done before going through more invasive and costly treatments like IVF or ICSI.
    VL  - 8
    IS  - 4
    ER  - 

    Copy | Download

Author Information
  • Department of Gynecology, Tarail Upazila Health Complex, Kishorganj, Bangladesh

  • Department of Dermatology and Venerology, Shaheed Syed Nazrul Islam Medical College Hospital, Kishorganj, Bangladesh

  • Department of Ear, Nose, and Throat, National Institute of Ear, Nose, and Throat, Tejgaon, Bangladesh

  • Department of Anesthesia, National Institute of Neurosciences and Hospital, Agargaon, Bangladesh

  • Department of Statistics, University of Rajshahi, Rajshahi, Bangladesh

  • Department of Pediatrics Neurology and Development, Shaheed Suhrawardy Medical College and Hospital, Dhaka, Bangladesh

  • Sections